Preneoplasia in the prostate gland with emphasis on high grade prostatic intraepithelial neoplasia

Pathology

Volumn 45, Issue 3, 2013, Pages 251-263

  Merrimen, Jennifer L O ^a   Evans, Andrew J ^b   Srigley, John R ^c  

^a DALHOUSIE UNIVERSITY   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

High grade prostatic intraepithelial neoplasia; HPIN; Precursor; Prostatic adenocarcinoma; Risk

Indexed keywords

EID: 84879648966     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1097/PAT.0b013e32835f6134     Document Type: Article

References (178)

1. Howlader N, Noone AM, Krapcho M, et al., editors. SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations). Bethesda, MD: National Cancer Institute, based on November 2011 SEER data submission, posted to the SEER web site 2012http://seer.cancer.gov/csr/1975-2009-pops09/.
2. McNeal JE. Morphogenesis of prostatic carcinoma. Cancer 1965; 18: 1659-66.
3. McNeal JE, Bostwick DG. Intraductal dysplasia: a premalignant lesion of the prostate. Hum Pathol 1986; 17: 64-71.
4. McNeal JE. Significance of duct-acinar dysplasia in prostatic carcinogenesis. Prostate 1988; 13: 91-102.
5. Bostwick DG, Brawer MK. Prostatic intra-epithelial neoplasia and early invasion in prostate cancer. Cancer 1987; 59: 788-94.
6. Prostatic intraepithelial neoplasia: significance and correlation with prostate specific antigen and transrectal ultrasound. Proceedings of a workshop National Prostate Cancer Detection Project; March 13, 1989, Bethesda, Maryland. Urology 1989; 34: 2-69.
7. Drago JR, Mostofi FK, Lee F. Introductory remarks and workshop summary. Urology 1989; 34: 2-3.
8. Bostwick DG, Qian J. High grade prostatic intraepithelial neoplasia. Mod Pathol 2004; 17: 360-79.
9. Oertel H. An address on involutionary changes in prostate and female breast in relation to cancer development. Can Med Assoc J 1926; 16: 237-41.
10. Andrews GS. Latent carcinoma of the prostate. J Clin Pathol 1949; 2: 197-208.
11. Bostwick DG, Montironi R, Sesterhenn IA. Diagnosis of prostatic intraepithelial neoplasia: Prostate Working Group/consensus report. Scan J Urol Nephrol Suppl 2000; 205: 3-10.
12. Nickel JC, Roehrborn CG, O'Leary MP, et al. The relationship between prostate inflammation and lower tract symptoms: examination of baseline data from the REDUCE trial. Eur Urol 2008; 54: 1379-84.
13. De Marzo AM, Platz EA, Sutcliffe S, et al. Inflammation in prostate carcinogenesis. Nat Rev Cancer 2007; 7: 256-69.
14. De Marzo AM, Platz EA, Epstein JI, et al. Aworking group classification of focal prostate atrophy lesions. Am J Surg Pathol 2006; 30: 1281-91.
15. Srigley JR. Benign mimickers of prostatic adenocarcinoma. Mod Pathol 2004; 17: 328-48.
16. Sfanos KS, De Marzo AM. Prostate cancer and inflammation: the evidence. Histopathology 2012; 60: 199-215.
17. Weitzman SA, Gordon LI. Inflammation and cancer: role of phagocytegenerated oxidants in carcinogenesis. Blood 1990; 76: 655-63.
18. Hadley CW, Miller EC, Schwartz SJ, et al. Tomatoes, lycopene and prostate cancer: progress and promise. Exp Biol Med 2002; 227: 869-80.
19. Franks LM. Atrophy and hyperplasia in the prostate proper. J Pathol Bacteriol 1954; 68: 617-21.
20. Ruska KM, Sauvageot J, Epstein JI, et al. Histology and cellular kinetics of prostatic atrophy. Am J Surg Pathol 1998; 22: 1073-7.
21. De Marzo AM, Marchi VL, Epstein JI, et al. Proliferative inflammatory atrophy of the prostate: implications for prostate carcinogenesis. Am J Surg Pathol 1999; 155: 1985-92.
22. Putzi MJ, De Marzo AM. Morphologic transitions between proliferative inflammatory atrophy and high-grade prostatic intraepithelial neoplasia. Urology 2000; 56: 828-32.
23. Wang W, Bergh A, Damber JE. Morphological transition of proliferative inflammatory atrophy to high-grade prostatic intraepithelial neoplasia and cancer in human prostate. Prostate 2009; 69: 1378-86.
24. Humphrey PA. Atypical adenomatous hyperplasia (adenosis) of the prostate. J Urol 2012; 188: 2371-2.
25. Bostwick DG, Qian J. Atypical adenomatous hyperplasia of the prostate. Relationship with carcinoma in 217 whole-mount radical prostatectomies. Am J Surg Pathol 1995; 19: 506-18.
26. Brawn PN. Adenosis of the prostate: a dysplastic lesion that can be confused with prostate adenocarcinoma. Cancer 1982; 49: 826-33.
27. Helpap B. Cell kinetic studies on prostatic intraepithelial neoplasia (PIN) and atypical adenomatous hyperplasia (AAH) of the prostate. Pathol Res Pathol 1995; 191: 904-7.
28. Cheng L, Shan A, Cheville JC, et al. atypical adenomatous hyperplasia of the prostate: a premalignant lesion? Cancer Res 1995; 58: 389-91.
29. Doll JA, Zhu X, Furman J, et al. Genetic analysis of prostatic atypical adenomatous hyperplasia (adenosis). Am J Pathol 1999; 155: 967-71.
30. Zhang C, Montironi R, MacLennan GT, et al. Is atypical adenomatous hyperplasia of the prostate a precursor lesion? Prostate 2011; 71: 1746-51.
31. Bettendorf O, Schmidt H, Eltze E, et al. Cytogenetic changes and loss of heterozygosity in atypical adenomatous hyperplasia, in carcinoma of the prostate and in non-neoplastic prostate tissue using comparative genomic hybridization and multiplex PCR. Int J Oncol 2005; 26: 267-74.
32. Bostwick DG, Amin MB, Dundore P, et al. Architectural patterns of high grade prostatic intraepithelial neoplasia. Hum Pathol 1993; 24: 298-310.
33. Argani P, Epstein JI. Inverted (hobnail) high grade prostatic intraepithelial neoplasia (PIN): report of 15 cases of a previously undescribed pattern of high grade PIN. Am J Surg Pathol 2001; 25: 1534-9.
34. Zhao J, Epstein JI. High-grade foamy gland prostatic adenocarcinoma on biopsy or transurethral resection: a morphologic study of 55 cases. Am J Surg Pathol 2009; 33: 583-90.
35. Reyes AO, swanson PE, Carbone JM, et al. Unusual histologic types of high-grade prostatic intraepithelial neoplasia. Am J Surg Pathol 1997; 21: 1215-22.
36. Berman DM, Yang J, Epstein JI, et al. Foamy gland high-grade prostatic intraepithelial neoplasia. Am J Surg Pathol 2000; 24: 140-4.
37. Melissari M, Lopez Beltran A, Bostwick DG, et al. High-grade prostatic intraepithelial neoplasia with squamous differentiation. J Clin Pathol 2006; 59: 437-9.
38. Epstein JI, Grignon DJ, Humphrey PA, et al. Interobserver reproducibility in the diagnosis of prostatic intraepithelial neoplasia. Am J Surg Pathol 1995; 19: 873-86.
39. Allam CK, Bostwick DG, Hayes JA, et al. Interobserver variability in the diagnosis of high-grade prostatic intraepithelial neoplasia and adenocarcinoma. Mod Pathol 1996; 9: 742-51.
40. Sakr W, Srigley JR, Dey J, et al. What features to urologic pathologists emphasize in diagnosing prostate lesions with equivocal changes of prostatic intraepithelial neoplasia (PIN)? A study of morphologic criteria and reproducibility. Mod Pathol 2001; 14: 122A.
41. Bostwick DG, Cheng L. Precursors of prostate cancer. Histopathology 2012; 60: 4-27.
42. Rubin MA, de la Taille A, Bagiella E, et al. Cribriform carcinoma of the prostate and cribriform prostatic intraepithelial neoplasia: incidence and clinical implications. Am J Surg Pathol 1998; 22: 840-8.
43. Hameed O, Humphrey PA. Immunohistochemistry and diagnostic surgical pathology of the prostate. Semin Diagn Pathol 2005; 22: 88-104.
44. Kunju LP, Rubin MA, Chinnaiyan AM, et al. Diagnostic usefulness of monoclonal antibody P504S and the workup of atypical prostatic glandular proliferations. Am J Clin Pathol 2003; 120: 737-45.
45. Kunju LP, Chinnaiyan AM, Shah RB. Comparison of monoclonal antibody (P504S) and polyclonal antibody to alpha-methylacyl-CoA racemase (AMACR) in the workup of prostate cancer. Histopathology 2005; 47: 587-96.
46. Rubin MA, Zhou M, Dhanasekaran SM, et al. Alpha-methylacyl coenzyme A racemase as a tissue bile marker for prostate cancer. JAMA 2002; 287: 1662-70.
47. Luo J, Zha S, Gage WR, et al. Alpha-methylacyl-CoA racemase: A new molecular marker for prostate cancer. Cancer Res 2002; 62: 2220-6.
48. Wu C-L, Yang XL, Tretiakova M, et al. Analysis of alpha-methylacyl- CoA racemase (P504S) expression in high-grade prostatic intraepithelial neoplasia. Hum Pathol 2004; 35: 1008-13.
49. Adley BP, Yang XJ. Application of alpha-methylacyl-coenzyme A racemase immunohistochemistry and the diagnosis of prostate cancer: a review. Anal Quant Cytol Histol 2006; 28: 1-13.
50. Brimo F, Epstein JI. Immunohistochemical pitfalls in prostate pathology. Hum Pathol 2012; 43: 313-24.
51. Bostwick DG, Ma J. Over diagnosis of high-grade prostatic intraepithelial neoplasia: a prospective study of 251 cases. BJU Int 2007; 100: 1036-9.
52. Kronz JD, Milord R, Wilentz R, et al. Lesions missed on prostate biopsies encases sent in for consultation. Prostate 2003; 54: 310-4.
53. Epstein JI, Cubilla AL, Humphrey PA. Tumors of the Prostate Gland, Seminal Vesicles, Penis and Scrotum. AFIP Atlas of Tumor Pathology. 4th series. Washington, DC: American Registry of Pathology, 2011; Chapter 1, The normal prostate gland.
54. Epstein JI, Yang XJ. Prostate Biopsy Interpretation. 3rd ed. Philadelphia: Lippincott Williams & Wilkins, 2002; Chapter 5, Prostatic intraepithelial neoplasia and its mimickers.
55. McNeal JE. Normal histology of the prostate. Am J Surg Pathol 1988; 12: 619-33.
56. Troncoso P, Babaian RJ, Roy JY, et al. Prostatic intraepithelial neoplasia and invasive prostatic carcinoma and cystoprostatectomy specimens. Urology 1989; 34: 52-6.
57. Harvei S, Skjorten FJ, Robsahm TE, et al. Is prostatic intraepithelial neoplasia in the transition/central zone a true. precursor of cancer? A longterm retrospective study in Norway. Br J Cancer 1998; 78: 46-9.
58. Arias-Stella J, Takano-Moron J. Atypical epithelial changes in the seminal vesicle. Arch Pathol 1958; 66: 761-6.
59. Kuo TT, Gomez LG. Monstrous epithelial cells in human epididymis and seminal vesicles. A pseudo-malignant change. Am J Surg Pathol 1981; 5: 483-90.
60. Amin MB, Bostwick DG. Pigment in prostatic epithelium and adenocarcinoma: A potential source of diagnostic confusion with seminal vesicular epithelium. Mod Pathol 1996; 9: 971-5.
61. Yantiss RK, Young RH. Transitional cell 'metaplasia' and the prostate gland: a survey of its frequency and features based on over 100 consecutive prostatic biopsy specimens. J Urol Pathol 1997; 7: 71-80.
62. Montironi R, Mazzucchelli R, Lopez-Beltran A, et al. Prostatic intraepithelial neoplasia: its morphological and molecular diagnosis and clinical significance. BJU Int 2011; 108: 1394-9.
63. Ayala AG, Srigley JR, Ro JY, et al. Clear cell cribriform hyperplasia of prostate. Report of 10 cases. Am J Surg Pathol 1996; 10: 665-71.
64. Grignon DJ, Ro JY, Ordonez NG, et al. Basal cell hyperplasia, adenoid basal cell tumor and adenoid cystic carcinoma of the prostate gland: an immunohistochemical study. Hum Pathol 1988; 19: 1425-33.
65. Young RH, Frierson HF, Mills SE, et al. Adenoid cystic like tumor of the prostate gland. A report of two cases and review of literature on 'adenoid cystic carcinoma' of the prostate. Am J Clin Pathol 1988; 89: 49-56.
66. McKenney JK, Amin MB, Srigley JR, et al. Basal cell proliferation to the prostate other than the usual basal cell hyperplasia: A clinicopathologic study of 23 cases, including four carcinomas, with a proposed classification. Am J Surg Pathol 2004; 28: 1289-98.
67. Humphrey PA, KaleemZ, Swanson PE, et al. Pseudohyperplastic prostatic adenocarcinoma. Am J Surg Pathol 1998; 22: 1239-46.
68. Levi AW, Epstein JI. Pseudohyperplastic adenocarcinoma on needle biopsy and simple prostatectomy. Am J Surg Pathol 2000; 24: 1039-46.
69. Arista-Nasr J, Martinez B, Fernandez-Amador JA, et al. Pseudohyperplastic prostatic adenocarcinoma in simple prostatectomy. Ann Diagn Pathol 2011; 15: 170-4.
70. Hameed O, Humphrey PA. Stratified epithelium in prostatic carcinoma: A mimic of high-grade prostatic intraepithelial neoplasia. Mod Pathol 2006; 19: 899-906.
71. Tavora F, Epstein JI. High-grade prostatic intraepithelial-like ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases. Am J Surg Pathol 2008; 32: 1060-7.
72. Amin MB, Grignon D, Humphrey PH, Srigley JR. Gleason Grading of Prostate Cancer: A Contemporary Approach. Philadelphia: Lippincott Williams & Wilkins, 2004.
73. McNeal JE, Yemoto CE. Spread of adenocarcinoma within prostatic ducts and acini: morphologic and clinical correlations. Am J Surg Pathol 1996; 20: 802-14.
74. Guo CC, Epstein JI. Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance. Mod Pathol 2006; 19: 1528-35.
75. Epstein JI. Precursor lesions to prostatic adenocarcinoma. Virchows Arch 2009; 454: 1-16.
76. Ayala AG, Ro JY. Prostatic intraepithelial neoplasia: recent advances. Arch Pathol Lab Med 2007; 131: 1257-66.
77. Melicow MM, Patcher MR. Endometrial carcinoma of the prostatic utricle (uterus masculinus). Cancer 1967; 20: 1715-22.
78. Randolph T, Amin MB, Ro JY. Histologic variants of prostatic adenocarcinoma and other carcinomas of the prostate. Mod Pathol 1997; 10: 612-29.
79. Humphrey PA. Histological variants of prostatic carcinoma and their significance. Histopathology 2012; 60: 59-74.
80. Samaratunga H, Singh M. Distribution pattern of basal cells detected by cytokeratin 34BE12 in primary prostatic duct adenocarcinoma. Am J Surg Pathol 1997; 21: 435-40.
81. Oxley JD, Abbott CD, Gillatt DA, et al. Ductal carcinoma of the prostate: a clinicopathological and immunohistochemical study. Br J Urol 1998; 81: 109-15.
82. Beach R, Gown AM, DePeralta-Venturina MN, et al. P504S immunohistochemical detection in 405 prostatic specimens including 376 18 gauge needle biopsies. Am J Surg Pathol 2002; 26: 1588-96.
83. Herawi M, Epstein JI. Immunohistochemical antibody cocktail (p63/HMWCK/AMACR) staining of ductal adenocarcinoma and Gleason pattern 4 cribriform and non-cribriform acinar adenocarcinoma of the prostate. Am J Surg Pathol 2007; 31: 889-94.
84. Amin A, Epstein JI. Pathologic stage of prostatic ductal adenocarcinoma at radical prostatectomy: effect of percentage of the ductal component and associated grade of acinar or adenocarcinoma. Am J Surg Pathol 2011; 35: 615-9.
85. Samaratunga H, Duffy D, Yaxley J, et al. Any proportion of ductal adenocarcinoma in radical prostatectomy specimens predicts extraprostatic extension. Hum Pathol 2010; 41: 281-5.
86. Cheng L, Montironi R, Bostwick DG. Villous adenoma of the urinary tract: a report of 23 cases, including 8 with coexistent adenocarcinoma. Am J Surg Pathol 1999; 23: 764-71.
87. Osunkoya AO, Epstein JI. Primary mucin-producing urothelial-type adenocarcinoma of prostate: report of 15 cases. Am J Surg Pathol 2007; 31: 1323-9.
88. Curtis MW, Evans AJ, Srigley J. Mucin-producing urothelial-type adenocarcinoma of prostate: report of two cases of a rare and diagnostically challenging entity. Mod Pathol 2005; 18: 585-90.
89. Sakr WA, Grignon DJ, Haas GP, et al. Age and racial distribution of prostatic intraepithelial neoplasia. Eur Urol 1996; 30: 138-44.
90. Sakr WA, Grignon DJ, Crissman JD, et al. High-grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinoma between the ages of 20-69: an autopsy study of 249 cases. In Vivo 1994; 8: 439-43.
91. Sakr WA, Grignon DJ, Haas GP, et al. Epidemiology of high-grade prostatic intraepithelial neoplasia. Pathol Res Pract 1995; 191: 838-41.
92. Soos G, Tsakiris I, Szanto J, et al. The prevalence of prostate carcinoma and its precursor in Hungary: an autopsy study. Eur Urol 2005; 48: 739-44.
93. Sanchez-Chapado M, Olmedilla G, Cabeza M, et al. Prevalence of prostate cancer and prostatic intraepithelial neoplasia in Caucasian and Mediterranean males: an autopsy study. Prostate 2003; 54: 238-47.
94. Billis A. Age and race distribution of high-grade prostatic intraepithelial neoplasia: an autopsy study in Brazil (South America). J Urol Pathol 1996; 5: 175-81.
95. Yatani R, Chigusa I, Akazaki K, et al. Geographic pathology of latent prostatic carcinoma. Int J Cancer 1982; 29: 611-6.
96. Han KS, Jeong IG, Joung JY, et al. Prevalence of high-grade prostatic intraepithelial neoplasia in prostate gland of Korean men: comparisons between radical prostatectomy and cystoprostatectomy. Urology 2007; 70: 1100-3.
97. Yang CR, Ou YC, Ho HC, et al. Unsuspected prostate carcinoma and prostatic intraepithelial neoplasm in Taiwanese patients undergoing cystoprostatectomy. Mol Urol 1999; 3: 33-9.
98. Tan PH, Tan HW, Lim CN, et al. Is high-grade prostatic intraepithelial neoplasia on needle biopsy different in an Asian population: A clinicopathologic study performed in Singapore. Urology 2006; 68: 800-3.
99. Epstein JI, Herawi M. Prostate needle biopsies containing prostatic intraepithelial neoplasia or atypical foci suspicious for carcinoma: implications for patient care. J Urol 2006; 175: 820-34.
100. Merrimen JL, Jones G, Walker D, et al. Multifocal high-grade prostatic intraepithelial neoplasia is a significant risk factor for prostatic adenocarcinoma. J Urol 2009; 182: 485-90.
101. Schoenfield L, Jones JS, Zippe CD, et al. The incidence of high-grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first time saturation needle biopsy, and the subsequent risk of cancer. BJU Int 2007; 99: 770-4.
102. Lane BR, Zippe CD, Abouassalay R, et al. Saturation technique and has not decreased cancer detection germ followup after initial prostate biopsy. J Urol 2008; 179: 1746-50.
103. Godoy G, Taneja SS. Contemporary clinical management of isolated highgrade prostatic intraepithelial neoplasia. Prostate Cancer Prostatic Dis 2008; 11: 20-31.
104. Amin MB, Ro JY, Ayala AG. Prostatic intraepithelial neoplasia - its relationship to prostate adenocarcinoma. In: Rosen PP, Fechner RE, editors. Pathology Annual 1994. Part 2. Norfolk, CT: Appleton Lange, 1994; 1-30.
105. Montironi R, Mazzucchelli R, Lopez-Beltran A, et al. Mechanisms of disease: high-grade prostatic intraepithelial neoplasia and other proposed preneoplastic lesions in the prostate. Nat Clin Pract Urol 2007; 4: 321-32.
106. McNeal JE, Villers A, Redwine EA, et al. Microcarcinoma in the prostate: its association with duct-acinar dysplasia. Hum Pathol 1991; 22: 644-52.
107. Qian J, Wollan P, Bostwick DG. The extent and multicentricity of highgrade prostatic intraepithelial neoplasia and clinically localized prostatic adenocarcinoma. Hum Pathol 1997; 57: 524-31.
108. Montironi R, Mazzucchelli R, Algaba F, et al. Morphological identification of the patterns of prostatic intraepithelial neoplasia and their importance. J Clin Pathol 2000; 59: 655-65.
109. Oyasu R, Bahnson RR, Nowels K, et al. Cytological atypia in the prostate gland: frequency, distribution and possible relevance to carcinoma. J Urol 1986; 135: 959-62.
110. Fujita MQ, Shin M, Yasunaga Y, et al. Incidence of prostatic intraepithelial neoplasia in Osaka, Japan. Int J Cancer 1997; 73: 808-11.
111. Shin M, Takayama H, Nonomura N, et al. Extent and zonal distribution of prostatic intraepithelial neoplasia in patients with prostatic carcinoma in Japan: analysis of whole mounted prostatectomy specimens. Prostate 2000; 42: 81-7.
112. Roscigno M, Scattoni V, Freschi M, et al. Diagnosis of high-grade prostatic intraepithelial neoplasia: the impact of the number of biopsy cores at initial sampling on cancer detection after a saturation rebiopsy. Arch Ital Urol Androl 2010; 82: 242-7.
113. Lee MC, Moussa AS, Zaytoun O, et al. Using a saturation biopsy scheme increase cancer detection during repeat biopsy in men with high grade prostatic intraepithelial neoplasia. Urology 2011; 78: 1115-9.
114. Herawi M, Kahane H, Cavallo C, et al. Risk of prostate cancer on first re biopsy within one year f ollowing a diagnosis of high-grade prostatic intraepithelial neoplasia is related to the number of cores sampled. J Urol 2006; 175: 121-4.
115. Eskicorapci SY, Guliyev F, Islamoglu E, et al. The effect of prior biopsy scheme on prostate cancer detection for repeat biopsy population: results of the 14 core prostate biopsy technique. Int Urol Nephrol 2007; 39: 189-95.
116. Rabets JC, Jones JS, Patel A, et al. Prostate cancer detection with office based saturation biopsy in a repeat biopsy population. J Urol 2004; 172: 94-7.
117. Abdel-Khalek M, El-Baz M, Ibrahiem el-H. Predictors of prostate cancer on extended biopsy in patients with high-grade prostatic intraepithelial neoplasia: a multivariate analysis model. BJU Int 2004; 94: 528-33.
118. Merrimen JL, Jones G, Srigley R. Is high-grade prostatic intraepithelial neoplasia still a risk factor for adenocarcinoma in the era of extended biopsy sampling? Pathology 2010; 42: 325-9.
119. Roscigno M, Scattoni V, Freschi M, et al. Multifocal and plurifocal highgrade prostatic intraepithelial neoplasia on extended prostate biopsies: factors predicting cancer detection on extended repeat biopsy. Urology 2004; 63: 1105-10.
120. Akhavan A, Keith JD, Bastacky SI, et al. The proportion of cores with high-grade prostatic intraepithelial neoplasia on extended pattern needle biopsy is significantly associated with prostate cancer on site directed repeat biopsy. BJU Int 2007; 99: 765-9.
121. Netto GJ, Epstein JI. Widespread high grade prostatic intraepithelial neoplasia on prostatic needle biopsy: a significant likelihood of subsequently diagnosed adenocarcinoma. Am J Surg Pathol 2006; 30: 1184-8.
122. Bishara T, Ramnani DM, Epstein JI. High-grade prostatic intraepithelial neoplasia on needle biopsy: risk of cancer on repeat biopsy related to number of involved cores and morphologic pattern. Am J Surg Pathol 2004; 28: 629-33.
123. De Nunzio C, Trucchi A, Miano R, et al. The number of cores positive for high-grade prostatic intraepithelial neoplasia on initial biopsy is associated with prostate cancer on second biopsy. J Urol 2009; 181: 1069-74.
124. Roscigno M, Scattoni V, Freschi M, et al. Diagnosis of isolated highgrade prostatic intraepithelial neoplasia: proposal of a nomogram for the prediction of cancer detection at saturation rebiopsy. BJU Int 2012; 109: 1329-34.
125. Kronz JD, Allan CH, Shaikh AA, et al. Predicting cancer following a diagnosis of high-grade prostatic intraepithelial neoplasia on needle biopsy: data on men with more than one followup biopsy. Am J Surg Pathol 2001; 25: 1079-85.
126. O'Dowd GJ, Miller MC, Orozco R, et al. Analysis of repeated biopsy results within one year after non-cancer diagnosis. Urology 2000; 55: 553-9.
127. Kamoi K, Troncoso P, Babaian RJ. Strategy for repeat biopsy in patients with high-grade prostatic intraepithelial neoplasia. JUrol 2000; 163: 819-23.
128. Stewart CS, Leibovich BC, Weaver AL, et al. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. J Urol 2001; 166: 86-91.
129. Park S, Shinohara K, Grossfeld GD, et al. Prostate cancer detection in men with prior high-grade prostatic intraepithelial neoplasia or atypical prostate biopsy. J Urol 2001; 165: 1409-14.
130. Borboroglu PG, Sur RL, Roberts JL, et al. Repeat biopsy strategy in patients with atypical small acinar proliferation or high-grade prostatic intraepithelial neoplasia on initial prostate needle biopsy. J Urol 2001; 166: 866-70.
131. Alsikafi NF, Brendler CB, Gerber GS, et al. High-grade prostatic intraepithelial neoplasia with adjacent atypia is associated with a higher incidence of cancer on subsequent needle biopsy than highgrade prostatic intraepithelial neoplasia alone. Urology 2001; 57: 296-300.
132. Maatman TJ, Papp SR, Carothers GG, et al. The critical role of patient followup after receiving a diagnosis of prostatic intraepithelial neoplasia. Prostate Cancer Prostatic Dis 2001; 4: 63-6.
133. Lefkowitz GK, Taneja SS, Brown J, et al. Followup interval prostate biopsy 3 years after diagnosis of high-grade prostatic intraepithelial neoplasia is associated with a high likelihood of prostate cancer, independent of change in prostate specific antigen levels. J Urol 2002; 168: 1415-8.
134. San Francisco IF, Olumi AF, Kao J, et al. Clinical management of prostatic intraepithelial neoplasia as diagnosed by extended needle biopsies. BJU Int 2003; 91: 350-4.
135. Goeman L, Joniau S, Ponette D, et al. Is low grade prostatic intraepithelial neoplasia a risk factor for cancer? Prostate Cancer Prostatic Dis 2003; 6: 305-10.
136. Postma R, Roobol M, Schroder FH, et al. Lesions predictive for prostate cancer in a screening population: first and second screening round findings. Prostate 2004; 61: 260-6.
137. Naya Y, Ayala AG, Tamboli P, et al. Can the number of cores with highgrade prostate intraepithelial neoplasia predict cancer and manual undergo repeat biopsy? Urology 2004; 63: 503-8.
138. Gokden N, Roehl KA, Catalona WJ, et al. High-grade prostatic intraepithelial neoplasia in needle biopsy as risk factor for detection of adenocarcinoma: current level of risk and screening population. Urology 2005; 65: 538-42.
139. Schlesinger C, Bostwick DG, Iczkowski KA. High-grade prostatic intraepithelial neoplasia and atypical small acinar proliferation: predictive value for cancer in current practice. Am J Surg Pathol 2005; 29: 1201-7.
140. Moore CK, Karikehalli S, Nazeer T, et al. Prognostic significance of highgrade prostatic intraepithelial neoplasia and atypical small acinar proliferation in the contemporary era. J Urol 2005; 173: 70-2.
141. Gallo F, Chiono L, Gastaldi E, et al. Prognostic significance of high-grade prostatic intraepithelial neoplasia (HGPIN): risk of prostate cancer on repeat biopsies. Urology 2008; 72: 628-32.
142. Singh PB, Nicholson CM, Ragavan N, et al. Risk of prostate cancer after detection of isolated high-grade prostatic intraepithelial neoplasia (HGPIN) on extended core needle biopsy: a UK hospital experience. BMC Urol 2009; 9: 3.
143. Bostwick DG, Kochar P, Hossain D, et al. High-grade prostatic intraepithelial neoplasia and atypical small acinar proliferation are significant cancer risk factors: followup study of 1476 cases. Mod Pathol 2009; 181: 752.
144. Ploussard G, Plennevaux G, Allory Y, et al. High-grade prostatic intraepithelial neoplasia and atypical small acinar proliferation on initial 21 core extended biopsy scheme: incidence and implications for patient care and surveillance. World J Urol 2009; 27: 587-92.
145. Laurila M, van der Kwast T, Bubendorf L, et al. Detection rates of cancer, high-grade PIN and atypical lesions suspicious for cancer in the European Randomized Study of Screening for Prostate Cancer. Eur J Cancer 2010; 46: 3068-72.
146. Lee MC, Moussa AS, Yu C, et al. Multifocal high-grade prostatic intraepithelial neoplasia is a risk factor for subsequent prostate cancer. J Urol 2010; 184: 1958-62.
147. Godoy G, Huang GJ, Patel T, et al. Long-term followup of men with isolated high-grade prostatic intraepithelial neoplasia followed by serial delayed interval biopsy. Urology 2011; 77: 669-74.
148. Meyer F, Tetu B, Bairati I, et al. Prostatic intraepithelial neoplasia in TURP specimens and subsequent prostate cancer. Can J Urol 2006; 13: 3255-60.
149. Pacelli A, Bostwick DG. Clinical significance of high-grade prostatic intraepithelial neoplasia in transurethral resection specimens. Urology 1997; 50: 355-9.
150. Gaudin PB, Sesterhenn IA, Wojno KJ, et al. Incidence and clinical significance of high-grade prostatic intraepithelial neoplasia in TURP specimens. Urology 1997; 49: 558-63.
151. Skorten FJ, Berner A, Harvei S, et al. Prostatic intraepithelial neoplasia in surgical resections: relationship to coexistent adenocarcinoma and atypical adenomatous hyperplasia of the prostate. Cancer 1997; 79: 1172-9.
152. Qian J, Bostwick DG, Takahashi S, et al. Chromosomal anomalies in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization. Cancer Res 1995; 55: 5408-14.
153. Emmert-Buck MR, Vocke CD, Pozzatti RO, et al. Allelic loss on chromosome 8p12-21 in micro-dissected prostatic intraepithelial neoplasia. Cancer Res 1995; 55: 2959-62.
154. Crissman JD, Sakr WA, Hussein ME, et al. DNA quantitation of intraepithelial neoplasia and invasive carcinoma of the prostate. Prostate 1993; 22: 155-62.
155. Weinberg DS, Weidner N. Concordance of DNA content between prostatic intraepithelial neoplasia and contaminant invasive carcinoma: evidence that prostatic intraepithelial neoplasia is a precursor of invasive prostatic carcinoma. Arch Pathol Lab Med 1993; 117: 1132-7.
156. Vukovic B, Park PC, Al-Maghrabi J, et al. Evidence of multifocality of teleomere erosion in high-grade prostatic intraepithelial neoplasia (HPIN) and concurrent carcinoma. Oncogene 2003; 22: 1978-87.
157. Meeker AK, Hicks JL, Platz EA, et al. Telomere shortening is an early somatic DNA alteration in human prostate tumor genesis. Cancer Res 2002; 62: 6405-9.
158. Koeneman KS, Pan CX, Jin JK, et al. Telemerase activity, telomere length and DNA ploidy in prostatic intraepithelial neoplasia (PIN). J Urol 1998; 160: 1533-9.
159. Brooks JD, Weinstein M, Lin X, et al. CG island ventilation changes near the GSTP1 gene in prostatic intraepithelial neoplasia. Cancer Epidemiol Biomarkers Prev 1998; 7: 531-6.
160. Bhatia-gaur R, Donjacour AA, Sciavolino PJ, et al. Roles for NKX3.1 in prostate development and cancer. Genes Dev 1999; 13: 966-77.
161. Cerveira N, Ribeiro FR, Peixoto A, et al. TMPRSS2-ERG gene fusion causing ERG overexpression precedes chromosome copy number changes in prostate carcinoma and paired HGPIN lesions. Neoplasia 2006; 8: 826-32.
162. Perner S, Mosquera JM, Demichelis F, et al. TMPRSS2-ERG fusion prostate cancer: an early molecular event associated with invasion. Am J Surg Pathol 2007; 31: 882-8.
163. Mosquera JM, Perner S, Genega S, et al. Characterization of TMPRSS2- ERG fusion high-grade prostatic intraepithelial neoplasia and potential clinical implications. Clin Cancer Res 2008; 14: 3380-5.
164. Davidson D, Bostwick DG, Qian J, et al. Prostatic intraepithelial neoplasia is a risk factor for adenocarcinoma: predictive accuracy and needle biopsies. J Urol 1995; 154: 1295-9.
165. Bostwick DG. Prostatic intraepithelial neoplasia (PIN): current concepts. J Cell Biochem Suppl 1992; 16H: 10-9.
166. Klein EA, Thompson IM. Chemoprevention of prostate cancer: an updated view. World J Urol 2012; 30: 189-94.
167. Balaji KC, Rabbani F, Tsai H, et al. Effect of neoadjuvant hormonal therapy on prostatic intraepithelial neoplasia and its prognostic significance. J Urol 1999; 162: 753-7.
168. Ferguson J, Zincke H, Ellison E, et al. Decrease of prostatic intraepithelial neoplasia following androgen deprivation therapy in patients with a stage T3 carcinoma treated by radical prostatectomy. Urology 1994; 44: 91-5.
169. Alberts SR, Novotny PJ, Sloan JA, et al. Flutamide in men with prostatic intraepithelial neoplasia: a randomized, placebo controlled chemoprevention trial. Am J Ther 2006; 13: 291-7.
170. Bono AV, Mazzucchelli R, Ferrari I, et al. Bicalutamide 50 mg monotherapy in patients with isolated high-grade PIN: findings in repeat biopsies at 6 months. J Clin Pathol 2007; 60: 443-6.
171. Zhigang Z, Wenlu S. Flutamide reduced prostate cancer development and prostate stem cell antigen mRNA expression in high-grade prostatic intraepithelial neoplasia. Int J Cancer 2008; 122: 864-70.
172. Price D, Stein B, Seiber P, et al. Toremifene for the prevention of prostate cancer in men with high grade prostatic intraepithelial neoplasia: results of a double blind, placebo controlled, phase IIB clinical trial. J Urol 2006; 176: 965-9; 70.
173. Thompson IM, Lucia MS, Redman MW, et al. Finasteride decreases the risk of prostatic intraepithelial neoplasia. J Urol 2007; 178: 107-9.
174. Andriole GL, Bostwick DG, Brawley OW, et al. Effect of dutasteride on the risk of prostate cancer. N Eng J Med 2010; 362: 1192-202.
175. Bostwick DG, Neumann R, Qian J, et al. Reversibility of prostatic intraepithelial neoplasia: implications for chemoprevention. Eur Urol 1999; 35: 492-5.
176. Arakawa A, Song S, Scardino PT, et al. High-grade prostatic intraepithelial neoplasia in prostates removed following irradiation failure in the treatment of prostatic adenocarcinoma. Pathol Res Pract 1995; 191: 868-72.
177. Gaudin PB, Zelefsky MJ, Leibel SA, et al. Histopathologic features of three-dimensional conformal external beam radiation therapy on benign and malignant prostate tissues. Am J Surg Pathol 1999; 23: 1021-31.
178. Cheng L, Cheville JC, Pisansky TM, et al. Prevalance and distribution of prostatic intraepithelial neoplasia in salvage radical prostatectomy specimens after radiation therapy. Am J Surg Pathol 1999; 23: 803-8.